Our goal is to ensure we provide you with product and technology innovations that can advance your RNAi program.

To learn more about your perspectives and experiences in using RNAi technologies,  we are conducting 30 minute scientific interviews with scientists who are RNAi users.

These interviews will focus on your experiences in using RNA interference technologies…the good, the bad, and the ugly.

We want users of all kinds of RNAi technologies to tell us what works, what doesn’t work, and what would make your life easier.

Please email our RNAi marketing team at RNAiMarketing <at> sial.com to let us know you are interested in participating.

To quote our VP of Marketing, Dr. Helge Bastian…“We want to help life science researchers address their research challenges and are committed, more than ever to support them on their way to new and revolutionary discoveries.”

Over the past decade, Sigma Life Science has built a repertoire of products and technologies to support the biological researcher. Part of our commitment to biology is to share our knowledge and resources with you.

If you’ve been following us over the last 30+ days, you have noticed that we are using social media as a means to get to know the biological community at a whole new level. We’ll continue this trend here. As we go forward look to sigmabioblogs.com for the skinny on new techniques, improving old techniques, exciting applications, war stories from technical services, and information about scientists from all over the bio community.

Here is a video of our President, Dave Smoller, to tell you the details.

Watch the video and then check out our great tools and techniques listed below.

• Targeted Genome editing
• Knock out research models
• Custom oligo services
• Biomolecules including antibodies and small molecules
• Reprogramming tools for stem cell research
• siRNA and shRNA’s for gene knockdown
• Biological search tool

Thanks for talking to us. We are having fun and hope you are too.

Welcome to Sigma Life Science. This is Where Bio Begins.